A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis.

Naminatsu TakaharaYousuke NakaiHironori IshigamiKei SaitoTatsuya SatoRyunosuke HakutaKazunaga IshigakiTomotaka SaitoTsuyoshi HamadaSuguru MizunoHirofumi KogureHiroharu YamashitaHiroyuki IsayamaYasuyuki SetoKazuhiko Koike

Published in: Investigational new drugs (2020)

Ip PTX combined with GnP was feasible and potentially effective in pancreatic cancer with peritoneal metastasis as a first-line treatment deserved further evaluations.

Keyphrases

radiation therapy
locally advanced
chemotherapy induced
tyrosine kinase
epidermal growth factor receptor